The epidemiology of congestive heart failure: Contributions from the Framingham Heart Study

Global Heart

Volumn 8, Issue 1, 2013, Pages 77-82

  Mahmood, Syed S ^a   Wang, Thomas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGESTIVE HEART FAILURE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 84875202351     PISSN: 22118160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gheart.2012.12.006     Document Type: Review

References (18)

1. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1446
2. R.S. Vasan, and D. Levy Defining diastolic heart failure: a call for standardized diagnostic criteria Circulation 101 2000 2118 2121
3. W.B. Kannel, W.P. Castelli, P.M. McNamara, P.A. McKee, and M. Feinleib Role of blood pressure in the development of congestive heart failure: the Framingham study N Engl J Med 287 1972 781 787
4. K.K. Ho, K.M. Anderson, W.B. Kannel, W. Grossman, and D. Levy Survival after the onset of congestive heart failure in Framingham Heart Study subjects Circulation 88 1993 107 115
5. K.K. Ho, J.L. Pinsky, W.B. Kannel, and D. Levy The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 Suppl A 1993 6A 13A
6. D. Levy, S. Kenchaiah, and M.G. Larson Long-term trends in the incidence of and survival with heart failure N Engl J Med 347 2002 1397 1402
7. D. Levy, M.G. Larson, R.S. Vasan, W.B. Kannel, and K.K. Ho The progression from hypertension to congestive heart failure JAMA 275 1996 1557 1562
8. W.B. Kannel, R.B. D'Agostino, H. Silbershatz, A.J. Belanger, P.W. Wilson, and D. Levy Profile for estimating risk of heart failure Arch Intern Med 159 1999 1197 1204
9. T.J. Wang, M.G. Larson, and D. Levy Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
10. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, and D. Levy Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction N Engl J Med 336 1997 1350 1355
11. T.J. Wang, J.C. Evans, E.J. Benjamin, D. Levy, E.C. LeRoy, and R.S. Vasan Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 2003 977 982
12. M. Jessup, W.T. Abraham, and D.E. Casey 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 119 2009 1977 2016
13. P.A. Heidenreich, M.A. Gubens, G.C. Fonarow, M.A. Konstam, L.W. Stevenson, and P.G. Shekelle Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction J Am Coll Cardiol 43 2004 1019 1026
14. World Health Organization Global Status Report on Noncommunicable Diseases 2010 2011 World Health Organization Geneva, Switzerland
15. J.J. McMurray, M.C. Petrie, D.R. Murdoch, and A.P. Davie Clinical epidemiology of heart failure: public and private health burden Eur Heart J 19 Suppl P 1998 9 16
16. A. Damasceno, B.M. Mayosi, and M. Sani The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries: results of the Sub-Saharan Africa Survey of Heart Failure Arch Intern Med 3 2012 1 9
17. World Health Organization World Health Statistics 2012 World Health Organization Geneva, Switzerland
18. M.D. Huffman, and D. Prabhakaran Heart failure: epidemiology and prevention in India Natl Med J India 23 2010 283 288